Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

Wouter Froyman(KU Leuven), C. Landolfo(Queen Charlotte's and Chelsea Hospital), Bavo De Cock(KU Leuven), Laure Wynants(KU Leuven), P. Sladkevicius(Lund University), A. C. Testa(Università Cattolica del Sacro Cuore), Caroline Van Holsbeke(Ziekenhuis Oost-Limburg), Ekaterini Domali(National and Kapodistrian University of Athens), Robert Fruscio(University of Milano-Bicocca), E. Epstein(Karolinska Institutet), Maria José Bernardo(Unidade Local de Saúde de São José), D. Franchi(European Institute of Oncology), Marek Kudła(Medical University of Silesia), Valentina Chiappa, Juan Luis Alcázar(Clinica Universidad de Navarra), Francesco Leone(University of Milan), F. Buonomo(IRCCS Materno Infantile Burlo Garofolo), Lauri Hochberg(University of South Florida), Maria Elisabetta Coccia(University of Florence), S. Guerriero(University of Cagliari), Nandita Deo(Whipps Cross University Hospital), L. Jokubkiene(Lund University), J. Kaijser(Ikazia Ziekenhuis), An Coosemans(Rega Institute for Medical Research), Ignace Vergote(Rega Institute for Medical Research), Jan Y. Verbakel(University of Oxford), T. Bourne(Queen Charlotte's and Chelsea Hospital), Ben Van Calster(Leiden University Medical Center), L. Valentin(Lund University), D. Timmerman(KU Leuven)
The Lancet Oncology
February 5, 2019
Cited by 188Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis